Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 6;14(3):817.
doi: 10.3390/cancers14030817.

Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers

Marina Alorda-Clara  1   2 , Margalida Torrens-Mas  1   2   3 , Pere Miquel Morla-Barcelo  1 , Toni Martinez-Bernabe  1   2 , Jorge Sastre-Serra  1   2   4 , Pilar Roca  1   2   4 , Daniel Gabriel Pons  1   2 , Jordi Oliver  1   2   4 , Jose Reyes  1   2   5
Affiliations
Review

Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers

Marina Alorda-Clara et al. Cancers (Basel). .

Abstract

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers with high mortality rates, especially when detected at later stages. Early detection of CRC can substantially raise the 5-year survival rate of patients, and different efforts are being put into developing enhanced CRC screening programs. Currently, the faecal immunochemical test with a follow-up colonoscopy is being implemented for CRC screening. However, there is still a medical need to describe biomarkers that help with CRC detection and monitor CRC patients. The use of omics techniques holds promise to detect new biomarkers for CRC. In this review, we discuss the use of omics in different types of samples, including breath, urine, stool, blood, bowel lavage fluid, or tumour tissue, and highlight some of the biomarkers that have been recently described with omics data. Finally, we also review the use of extracellular vesicles as an improved and promising instrument for biomarker detection.

Keywords: blood; bowel lavage fluid; breath; colorectal cancer; extracellular vesicles; omics; stool; tumour tissue; urine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Main types of samples and the omics applied to them.
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Sociedad Española de Oncología Médica Las Cifras del Cáncer en España 2020. 2020. [(accessed on 24 December 2021)]. Available online: https://seom.org/prensa/el-cancer-en-cifras.
    1. Zamorano-Leon J.J., López-De-Andres A., Álvarez-González A., Maestre-Miquel C., Astasio-Arbiza P., López-Farré A., De-Miguel-Diez J., Jiménez-García R., Albaladejo-Vicente R. Trends and Predictors for the Uptake of Colon Cancer Screening Using the Fecal Occult Blood Test in Spain from 2011 to 2017. Int. J. Environ. Res. Public Health. 2020;17:6222. doi: 10.3390/ijerph17176222. - DOI - PMC - PubMed
    1. Roselló S., Simón S., Cervantes A. Programmed colorectal cancer screening decreases incidence and mortality. Transl. Gastroenterol. Hepatol. 2019;4:84. doi: 10.21037/tgh.2019.12.13. - DOI - PMC - PubMed
    1. Cheshomi H., Matin M.M. Exosomes and their importance in metastasis, diagnosis, and therapy of colorectal cancer. J. Cell. Biochem. 2019;120:2671–2686. doi: 10.1002/jcb.27582. - DOI - PubMed

LinkOut - more resources